NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Mediwhale

Mediwhale

Private
SeoulHealthcare & Life Scienceshttps://mediwhale.com/

Last Round

Series C

Mar 31, 2026

Total Funding Raised

$34.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mediwhale is a healthcare technology company that specializes in artificial intelligence-driven diagnostics to assess health risks via retinal scans for the early detection of cardiovascular, kidney, and eye diseases, facilitating preventive care in primary care environments.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

medical AIretinal imagingAI diagnosticscardiovascular risk assessmentsoftware as a medical deviceSaMDeye screeningretina scanpredictive health analyticschronic disease managementfundus cameradigital healthhealthtechAI screeningautomated diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mediwhale Comps

Public and private peers based on sector, stage, and business model.

Mediwhale comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mediwhale Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 31, 2026
Series B ExtensionSep 25, 2024
Series AApr 18, 2023

Key People

Founding team and executive leadership

Kevin Choi

CEO

Executive Team

Nina Nahyeon Shin

Chief Operating Officer (COO), COO

Executive Team

Young Lee

Chief Product Officer

Executive Team

Mediwhale Investors

Notable investors and investment history

Mediwhale investors
InvestorRounds
Hana VenturesSeries C
IMM InvestmentSeries C
KB InvestmentSeries C
HTASeries A
Premier PartnersSeries C
Mirae Asset SecuritiesSeries B Extension
QUAD Investment ManagementSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 53% MoM to 10.8K.

  • Mar 31, 2026

    $13.3M round completed.

Mediwhale Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mediwhale Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mediwhale's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range47
Year Founded2016
Last FundingMar 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.